1. Overexpression of microRNA-96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via MTSS1;Yin;Exp. Ther. Med.,2020
2. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial;Chen;J. Immunother. Cancer,2020
3. Overexpression of 14-3-3σ modulates cholangiocarcinoma cell survival by PI3K/Akt signaling;Wu;BioMed Res. Int.,2020
4. Overexpression of 14-3-3sigma modulates cholangiocarcinoma cell survival by PI3K/Akt signaling;Wu;BioMed Res. Int.,2020
5. Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI;Li;Sci. Rep.,2017